Related content

Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™

By Barrett-Connor E.  

Osteoporosis International, Vol. 23, Iss. 2, 2012-02 ,pp. : 733-741

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU^® study

By Roux C.   Cooper C.   Díez-Pérez A.   Martinez L.   Ortolani S.   Gitlin M.   Möller G.   Shepherd S.   Freemantle N.  

Osteoporosis International, Vol. 22, Iss. 4, 2011-04 ,pp. : 1227-1236

Springer Publishing Company

Access to resources Recommend Favorite

An evaluation of patient preferences for osteoporosis medication attributes: results from the PREFER-US study

By Weiss Thomas W.   Gold Deborah T.   Silverman Stuart L.   McHorney Colleen A.  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 949-960

Informa Healthcare

Access to resources Recommend Favorite

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

By Cramer Joyce A.   Amonkar Mayur M.   Hebborn Ansgar   Altman Roy  

Current Medical Research and Opinion, Vol. 21, Iss. 9, 2005-09 ,pp. : 1453-1460

Informa Healthcare

Access to resources Recommend Favorite

Gastrointestinal side effects in postmenopausal women using osteoporosis therapy: 1-year findings in the POSSIBLE US study

By Woo Claudine   Gao Guozhi   Wade Sally   Hochberg Marc C.  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 1003-1009

Informa Healthcare

Access to resources Recommend Favorite